Management of Asymptomatic Erosive Esophagitis: An E-Mail Survey of Physician’s Opinions
1
조회
0
다운로드
1
인용
0
참고문헌
초록
Background/Aims: The management of asymptomatic erosive esophagitis is controversial. We surveyed physicians’opinions on asymptomatic erosive esophagitis using e-mail. Methods: All members of the Korean Society of Neurogastroenterology and Motility were invited to answer the questionnaire on the treatment and follow-up of patients with asymptomatic erosive esophagitis by e-mail. Results: A total of 73members answered the questionnaire (response rate, 18%). As initial management, 41% of respondents chose pharmacologic treatment, whereas 59% chose nonpharmacologic treatment. In the case of pharmacologic treatment, proton pump inhibitors were the preferred medication. The most common treatment duration was 4 weeks (43%), followed by 8 weeks (38%), and 6 months (11%). Sixty-two percent of the respondents recommended follow-up endoscopy annually,whereas 29% chose no endoscopic follow-up. Thirty-four percent of the respondents answered that they would talk about reflux-related sleep disturbances. Only 25% of the respondents explained the possibility of Barrett’s esophagus or esophageal adenocarcinoma to their patients. Conclusions:There are substantial practice variations in the management of asymptomatic erosive esophagitis in Korea
Abstract
Background/Aims: The management of asymptomatic erosive esophagitis is controversial. We surveyed physicians’opinions on asymptomatic erosive esophagitis using e-mail. Methods: All members of the Korean Society of Neurogastroenterology and Motility were invited to answer the questionnaire on the treatment and follow-up of patients with asymptomatic erosive esophagitis by e-mail. Results: A total of 73members answered the questionnaire (response rate, 18%). As initial management, 41% of respondents chose pharmacologic treatment, whereas 59% chose nonpharmacologic treatment. In the case of pharmacologic treatment, proton pump inhibitors were the preferred medication. The most common treatment duration was 4 weeks (43%), followed by 8 weeks (38%), and 6 months (11%). Sixty-two percent of the respondents recommended follow-up endoscopy annually,whereas 29% chose no endoscopic follow-up. Thirty-four percent of the respondents answered that they would talk about reflux-related sleep disturbances. Only 25% of the respondents explained the possibility of Barrett’s esophagus or esophageal adenocarcinoma to their patients. Conclusions:There are substantial practice variations in the management of asymptomatic erosive esophagitis in Korea
참고문헌 (33)
- Fass R, "Clinical consequences of silent gastroesophageal reflux disease", Curr Gastroenterol Rep, 8, pp.195~201 (2006)
- Yi SY, "Epidemiologic study of reflux esophagitis in general health screening people", Korean J Med, 46, pp.514~520 (1994)
- Jung SA, "The prevalence of reflux esophagitis of Korean adults for 10 years of 1990’s", Korean J Gastrointest Motil, 7, pp.161~167 (2001)
- 오정환, "역류성 식도염으로 진단된 건강 검진자의 임상상", Journal of Neurogastroenterology and Motility (JNM), 12(1), pp.12~18 (2006), 대한소화기 기능성질환∙운동학회
- Cho YS, "Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea", Am J Gastroenterol, 100, pp.747~753 (2005)
- 유승석, "건강진단검사 수진자에서 식도질환의 유병률", 대한소화기학회지, 50(5), pp.306~312 (2007), 대한소화기학회
- Ji Hyun Kim, "Endoscopic findings around the gastroesophageal junction: an experience from a tertiary hospital in Korea", The Korean Journal of Internal Medicine, 23(3), pp.127~133 (2008), 대한내과학회
- 황진기, "국내 2-3차 의료기관에서 관찰된 미란 식도염의 유병률 및 증상 분포", 대한소화기학회지, 53(5), pp.283~291 (2009), 대한소화기학회
- "Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: A population-based study", DIGESTIVE DISEASES AND SCIENCES, 53, pp.188~193 (2008)
- "Clinical significance of minimal change lesions of the esophagus in a healthy Korean population: A nationwide multi-center prospective study", JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 23(7 Pt 1), pp.1153~1157 (2008), BLACKWELL PUBLISHING ASIA
- "Prevalence of endoscopic reflux esophagitis among Koreans", J GASTROEN HEPATOL, Vol.16, No.4, pp.373~376 (2001), Gastroenterol Hepatol
- 손주익, "무증상 역류성 식도염의 자연 경과 - 건강 검진자를 대상으로 한 후향적 연구", Journal of Neurogastroenterology and Motility (JNM), 10(2), pp.100~104 (2004), 대한소화기 기능성질환∙운동학회
- Fass R, "Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease: where next?", Aliment Pharmacol Ther, 22, pp.79~94 (2005)
- Kaltenbach T, "Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach", Arch Intern Med, 166, pp.965~971 (2006)
- Kahrilas PJ, "American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease", Gastroenterology, 135, pp.1383~1391 (2008)
- Bell NJ, "Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease", Gut, 33, pp.118~124 (1992)
- Chiba N, "Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis", Gastroenterology, 112, pp.1798~1810 (1997)
- El-Serag HB, "Is the length of newly diagnosed Barrett’s esophagus decreasing? The experience of a VA Health Care System", Clin Gastroenterol Hepatol, 2, pp.296~300 (2004)
- Koop H, "An evidence-based look at pharmacotherapy for gastroesophageal reflux", Chirurg, 76, pp.353~358 (2005)
- Kahrilas PJ, "American Gastroenterological Association Institute; Clinical Practice and Quality Management Committee. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease", Gastroenterology, 135, pp.1392~1413 (2008)
- DeVault KR, "Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology", J Gastroenterol, 94, pp.1434~1442 (1999)
- Schey R, "Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease", Gastroenterology, 133, pp.1787~1795 (2007)
- Dickman R, "Relationships between sleep quality and pH monitoring findings in persons with gastroesophageal reflux disease", J Clin Sleep Med, 3, pp.505~513 (2007)
- Chen CL, "Sleep symptoms and gastroesophageal reflux", J Clin Gastroenterol, 42, pp.13~17 (2008)
- Hoffstein V, "Predictive value of clinical features in diagnosing obstructive sleep apnea", Sleep, 16, pp.118~122 (1993)
- Orr WC, "Heartburn: another danger in the night?", Chest, 127, pp.1486~1488 (2005)
- 이준행, "바렛식도 - 내시경진단을 중심으로", Clinical Endoscopy, 39(4), pp.185~198 (2009), 대한소화기내시경학회
- Hirota WK, "Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data", Gastroenterology, 116, pp.277~285 (1999)
- Cameron AJ, "Prevalence of columnar-lined (Barrett’s) esophagus. Comparison of population-based clinical and autopsy findings", Gastroenterology, 99, pp.918~922 (1990)
- Inadomi JM, "Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis", Ann Intern Med, 138, pp.176~186 (2003)
- Lagergren J, "Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma", N Engl J Med, 340, pp.825~831 (1999)
- Dulai GS, "Preoperative prevalence of Barrett’s esophagus in esophageal adenocarcinoma: a systematic review", Gastroenterology, 122, pp.26~33 (2002)
- Ching-Liang Lu, "Silent Gastroesophageal Reflux Disease", Journal of Neurogastroenterology and Motility (JNM), 18(3), pp.236~238 (2012), 대한소화기 기능성질환∙운동학회[DOI]